Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung

Journal of Cellular Biochemistry

Volumn 67, Issue SUPPL. 27, 1997, Pages 20-25

  Lantry, Laura E ^a   Zhang, Zhongqiu ^a   Gao, Feng ^a   Crist, Keith A ^a   Wang, Yian ^a   Kelloff, Gary J ^b   Lubet, Ronald A ^b   You, Ming ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CAAX motif; Farnesyltransferase inhibitor; K ras; Lung cancer; Monoterpene

Indexed keywords

PERILLYL ALCOHOL; UNCLASSIFIED DRUG; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ANTINEOPLASTIC AGENT; CARCINOGEN; NITROSAMINE; TERPENE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOASSAY; BIOLOGICAL MODEL; C3H MOUSE; CHEMICALLY INDUCED DISORDER; GENETICS; LUNG TUMOR; ONCOGENE RAS;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL ASSAY; CARCINOGENS; GENES, RAS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C3H; MODELS, BIOLOGICAL; MONOTERPENES; NITROSAMINES; TERPENES;

EID: 0031321471     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1997)27+<20::AID-JCB6>3.0.CO;2-3     Document Type: Article

References (38)

1. Faber LP (1991): Lung cancer. In Holleb AI, Fink DJ, Murphy GP (eds): "Clinical Oncology." Atlanta: American Cancer Society, Inc, 194-212.
2. Hecht SS, Hoffmann D (1988): Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9:875-884.
3. Hecht SS, Hoffmann D (1989): The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 8:273-294.
4. Mitra G, Pauly G, Kumar R, Pei G, Hughes S, Moschel R, Barbacid M (1989): Molecular analysis of O6-substituted guanine-induced mutagenesis of ras oncogenes. Proc Natl Acad Sci USA 86:8650-8654.
5. Belinsky SA, Foley JF, White CM, Anderson MW, Maronpot RR (1990): Dose-response between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 50:3772-3780.
6. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW (1989): Activation of the Ki-ras protoncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86:3070-3074.
7. Matzinger SA, Gunning WT, You M, Castonguay A (1994): Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice. Mol Carcinogen 11:42-48.
8. Barbacid M (1987): ras genes. Ann Rev Biochem 56:779-827.
9. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M (1987): Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303.
10. Bos JL (1989): ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
11. Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF (1995): Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 15:3654-3663.
12. Moores SL, Schaber MD, Mosser SD, Rands E, O'Hara MB, Garsky VM, Marshall MS, Pompliano DL, Gibbs JB (1991): Sequence dependence of protein isoprenylation. J Biol Chem 266:14603-14610.
13. Gutierrez L, Magee AI, Marshall CJ, Hancock JF (1989): Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J 8:1093-1098.
14. Hancock JF, Magee AI, Childs JE, Marshall CJ (1989): All Ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57:1167-1177.
15. Casey PJ, Solski PA, Der CJ, Buss JE (1989): p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 86:8323-8327.
16. Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ (1990): Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci USA 87:3042-3046.
17. Gibbs JB, Kohl NE, Koblan KS, Omer CA, Sepp-Lorenzino L, Rosen N, Anthony NJ, Conner MW, deSolms SJ, Williams TM, Graham SL, Hartman GD, Oliff A (1996): Farnesyltransferase inhibitors and anti-Ras therapy. Breast Cancer Res Treat 38:75-83.
18. Stacey DW, Feig LA, Gibbs GB (1991): Dominant inhibitory ras mutants selectively inhibit the activity of either cellular or oncogenic ras. Mol Cell Biol 11:4053-4064.
19. Medema RH, Wubbolts R, Bos JL (1991): Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol Cell Biol 11:5963-5967.
20. Crowell PL, Chang RR, Ren ZB, Elson CE, Gould MN (1991): Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266:17679-17685.
21. Gelb MH, Tamanoi F, Yokoyama K, Ghomashchi F, Esson K, Gould MN (1995): The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett 91:169-175.
22. Jirtle RL, Haag JD, Ariazi EA, Gould MN (1993): Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res 53:3849-3852.
23. Haag JD, Gould MN (1994): Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34: 477-483.
24. Stark MJ, Burke YD, McKinzie JH, Ayoubi AS, Crowell PL (1995): Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett 96:15-21.
25. Reddy BS, Wang C-X, Samaha H, Lubet RA, Steele VE, Kelloff GJ, Rao CV (1997): Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57:420-425.
26. Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL (1995): Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55:979-983.
27. Schulz S, Buhling F, Ansorge S (1994): Prenylated proteins and lymphocyte proliferation: Inhibition by d-limonene related monoterpenes. Eur J Immunol 24: 301-307.
28. Stoner G, Shimkin M, Kniazeff A, Weisburger J, Weisburger EK, Gori G (1973): Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res 33:3069-3085.
29. Castonguay A, Lin D, Stoner GD, Radok P, Furuya K, Hecht SS, Schut HA, Klaunig JE (1983): Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues. Cancer Res 43:1223-1229.
30. Chen B, You L, Wang Y, Stoner GD, You M (1994): Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Carcinogenesis 15:2031-2035.
31. Jackson JH, Li JW, Buss JE, Der CJ, Cochrane CG (1994): Polylysine domain of K-ras 4B protein is crucial for malignant transformation. Proc Natl Acad Sci USA 91:12730-12734.
32. James GL, Goldstein JL, Brown MS (1995): Polylysine and CVIM sequences of K-rasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J Biol Chem 270:6221-6226.
33. Crowell PL, Ren Z, Lin S, Vedejs E, Gould MN (1994): Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 47:1405-1415.
34. Morse MA, Toburen AL (1996): Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limonene. Cancer Lett 104:211-217.
35. Wattenberg LW, Coccia JB (1991): Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12:115-117.
36. Elegbede JA, Maltzman TH, Elson CE, Gould MN (1993): Effects of anticarcinogenic monoterpenes on Phase II hepatic metabolizing enzymes. Carcinogenesis 14:1221-1223.
37. Hohl RJ, Lewis K (1995): Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 270:17508-17512.
38. Ron Z, Gould MN (1994): Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. Cancer Lett 76:185-190.